This week, Bupa is calling for a 15% reduction in the cost of private healthcare. Damien Marmion, MD of Bupa, says there is a danger that the sector could "flat-line and then decline if nothing is done” and that that "the industry needs to urgently rethink how it sets prices". "We are asking the sector to come together to reduce costs by at least 15% to reach a point where affordability gets better. The whole sector has failed to provide the right outcome for customers. Private healthcare needs to be much more affordable".

Is he right?

What kind of reaction will this get from the hospitals, clinics and doctors whom he is asking to reduce prices (or make cost savings) of 15%?

Finding a way of delivering affordable private healthcare is essential for the future growth of the private healthcare sector. Private healthcare is faced with similar challenges to the NHS but in some cases may be handling them less effectively.

Challenge 1: Demographics

We all know that there’s a change in demographics…which means that people are living longer, creating greater demand for healthcare and thus making more use of their private medical insurance as they get older. More use ultimately means higher monthly premiums. And as subscribers pass the 50 mark, individual purchasers and corporate purchasers baulk at the steep increase in premiums. So, not surprisingly, we are seeing a fall in the number of people covered by PMI. The number of individuals with health cover has fallen to the lowest point in the last 20 years, and there’s no sign of recovery. According to Stephen Collier of BMI Healthcare at the Future of Private Healthcare Summit, “There’s a declining PMI caseload; the ice cube is still melting”.

It’s likely that the traditional PMI model has had its day; but what will replace it? How can we deliver affordable private health insurance to an ageing population who will be subject to continued rationing of NHS services?

Challenge 2: Healthcare cost inflation

Pharmaceutical companies, medical technology companies and device manufacturers want to maximise their revenues. Healthcare doesn’t stand still. Innovative treatments and technologies appear every day but boost healthcare costs.

New and more effective treatments often cost more than existing treatments. The introduction of new cancer drugs and their related cost have contributed significantly to healthcare cost inflation. Thus the “cost per case” often goes up. In some cases, new surgical approaches have helped to reduce cost per case. The development of minimally invasive surgery has certainly been a factor in reducing length of stay and associated hospital and care costs.

New treatments appear for conditions that were previously untreatable and generate new costs of care for both NHS and the private healthcare sector. The introduction of Lucentis, a novel treatment for macular degeneration in the elderly, added around £150 million to the NHS drugs bill when it was launched, and has prompted insurers to seek ways of limiting treatment under existing insurance plans.

If healthcare cost inflation is a given, then should we just accept that increasing prices for private healthcare are inevitable?

Challenge 3: Infrastructure

The UK’s private healthcare infrastructure is based on an out of date model. Many of our private hospitals were built in the private healthcare boom of the 1980’s…but if you built a private hospital today it would (or should) look very different. A typical private hospital consists of 50 or so inpatient beds, a daycase unit and supporting services. The NHS Modernisation Agency (later to become the NHS Institute for Innovation and Improvement) believed that we should be ‘treating day surgery (rather than inpatient surgery) as the norm for elective surgery”. Day surgery with the benefit of the latest minimally invasive techniques is more efficient and it’s what patients want. The balance of private v daycase surgery in the private healthcare sector has followed the NHS trend. But in many cases day surgery in our private hospitals is being delivered in a less efficient inpatient setting.

If you built a private hospital for the 2020’s what would it look like?

Challenge 4: Service delivery model

The insurer (Bupa) v Consultant battle has been going on for some while. Damien Marmion’s comments are to some extent aimed at the consultant fraternity who want to remain immune to the market forces. For many years, consultants have remained comfortable in the knowledge that there’s a healthy private market and there’s little discussion (or knowledge) about what consultants charge. The Competition and Markets Authority inquiry drags on but its initial recommendations are a wake-up call for the UK’s private practitioners. The inquiry has driven a new world of price transparency in private healthcare. In our recent PrivateHealthcare UK Self-Pay Market Study, we were able to analyse over 7,800 published prices for the most common procedures available in private hospitals. But the private medical profession has lagged behind. Few consultants are prepared to be open about their consultation and procedure fees or publish these online in sites such as Indeed, the Federation of Independent Practitioner Organisations (FIPO) is appealing against the CMA requirement for the publication of fee information. This may be a lost cause and they may have to face the inevitable.

The involvement of consultants in the delivery of private treatment will also need to change, if private healthcare is to become more affordable. In the NHS, some services are moving to delivery by nurse practitioners (at lower cost), under the guidance of a supervising consultant. The employment of consultant level staff by private hospitals is likely to be a next step to enable private healthcare providers to control the proportion of costs “controlled” by consultant surgeons.

“Old school” consultants may see these changes as a major threat to their autonomy. But the newer consultant coming into private practice may be more open minded and view such changes as an opportunity to grow their private practice income quickly.


Latest news

The London Clinic launches osseointegration

The London Clinic and Schoen Clinic London form partnership

30,000 people are diagnosed with ankle arthritis annually

How can we deliver affordable private healthcare?

About the author

Keith Pollard is Executive chairman of LaingBuisson International Limited, an online publisher in the healthcare sector that operates market-leading web portals such as Private Healthcare UK and LaingBuisson International Limited is also active in the online medical travel sector through Treatment Abroad, International Medical Travel Journal and DoctorInternet, the Arabic medical tourism portal. View for my full profile.

Filter by topic

Find a ...